BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.17M | -1.24M | 453.20K | -621.70K | -1.05M |
| Total Depreciation and Amortization | 2.22M | 2.25M | 2.29M | 2.33M | 2.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 829.90K | -1.89M | -2.15M | -489.60K | -489.60K |
| Change in Net Operating Assets | 1.47M | 7.16M | 4.76M | 4.15M | 2.11M |
| Cash from Operations | 351.40K | 6.28M | 5.36M | 5.36M | 2.94M |
| Capital Expenditure | -418.20K | -346.20K | -359.80K | -51.20K | -238.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.67M | -6.40M | -6.12M | -- | -- |
| Cash from Investing | -7.08M | -6.75M | -6.48M | -51.20K | -238.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00 | 0.00 | -447.20K | -447.20K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 0.00 | -447.20K | -447.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.73M | -462.10K | -1.13M | 4.86M | 2.26M |